Letter to the Editor March 15, 2014

Correction: Continuation of Quetiapine Versus Switching to Placebo or Lithium for Maintenance Treatment of Bipolar I Disorder (Trial 144: A Randomized Controlled Study)

J Clin Psychiatry 2014;75(3):290

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

In the article “Continuation of Quetiapine Versus Switching to Placebo or Lithium for Maintenance Treatment of Bipolar I Disorder (Trial 144: A Randomized Controlled Study)” by Richard H. Weisler, MD, and colleagues in the November 2011 issue (J Clin Psychiatry 2011;72[11]:1452-1464), in Figure 2 on page 1456, the number of patients randomized to quetiapine who discontinued due to mood event should be n=87.

The staff regret the error. The online article at PSYCHIATRIST.COM has been corrected.

This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

doi:10.4088/JCP.13lcx08958).

Correction

In the article “Continuation of Quetiapine Versus Switching to Placebo or Lithium for Maintenance Treatment of Bipolar I Disorder (Trial 144: A Randomized Controlled Study)” by Richard H. Weisler, MD, and colleagues in the November 2011 issue (J Clin Psychiatry 2011;72[11]:1452-1464), in Figure 2 on page 1456, the number of patients randomized to quetiapine who discontinued due to mood event should be n = 87.

The staff regret the error. The online article at PSYCHIATRIST.COM has been corrected.